⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for undifferentiated ovarian carcinoma

Every month we try and update this database with for undifferentiated ovarian carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT00719303
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Behavioral Diet...
Compliance Moni...
Counseling
Educational Int...
Exercise Interv...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - GOG Foundation
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerNCT01074411
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Ovarian Transit...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Undifferentiate...
Bortezomib
Carboplatin
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI)
TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerNCT01294293
Malignant Ovari...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
TLR8 Agonist VT...
Diagnostic Labo...
Pharmacological...
Pegylated Lipos...
Paclitaxel
18 Years - GOG Foundation
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerNCT01074411
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Ovarian Transit...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Undifferentiate...
Bortezomib
Carboplatin
Laboratory Biom...
Pharmacological...
18 Years - National Cancer Institute (NCI)
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerNCT02283658
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Everolimus
Laboratory Biom...
Letrozole
18 Years - Mayo Clinic
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerNCT02111941
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Laboratory Biom...
Multi-epitope F...
18 Years - Mayo Clinic
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerNCT00262847
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Bevacizumab
Carboplatin
Laboratory Biom...
Paclitaxel
Placebo
Quality-of-Life...
18 Years - National Cancer Institute (NCI)
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerNCT00060359
Fallopian Tube ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Primary Periton...
Stage III Ovari...
Stage IV Ovaria...
Undifferentiate...
Carboplatin
Paclitaxel Poli...
Pharmacological...
18 Years - GOG Foundation
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT00719303
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Behavioral Diet...
Compliance Moni...
Counseling
Educational Int...
Exercise Interv...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - GOG Foundation
Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerNCT01459380
Ovarian Clear C...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Bevacizumab
Carboplatin
Laboratory Biom...
Pegylated Lipos...
Veliparib
18 Years - National Cancer Institute (NCI)
Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerNCT01459380
Ovarian Clear C...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Bevacizumab
Carboplatin
Laboratory Biom...
Pegylated Lipos...
Veliparib
18 Years - National Cancer Institute (NCI)
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyNCT00899093
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Malignant Ovari...
Ovarian Adenoca...
Primary Periton...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Undifferentiate...
Cytology Specim...
Laboratory Biom...
18 Years - GOG Foundation
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerNCT02283658
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Undifferentiate...
Everolimus
Laboratory Biom...
Letrozole
18 Years - Mayo Clinic
A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerNCT00939809
Fallopian Tube ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Primary Periton...
Recurrent Ovari...
Undifferentiate...
Urokinase-Deriv...
Laboratory Biom...
18 Years - GOG Foundation
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyNCT01080521
Cognitive Side ...
Malignant Ovari...
Ovarian Brenner...
Ovarian Carcino...
Ovarian Chorioc...
Ovarian Clear C...
Ovarian Dysgerm...
Ovarian Embryon...
Ovarian Endomet...
Ovarian Mixed G...
Ovarian Mucinou...
Ovarian Polyemb...
Ovarian Sarcoma
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Teratom...
Ovarian Yolk Sa...
Stage I Ovarian...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage II Ovaria...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Primar...
Undifferentiate...
Cognitive Asses...
Quality-of-Life...
18 Years - GOG Foundation
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: